Status: Not yet recruiting
21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia
Our aim is to test the hypothesis that a 3-week course of albendazole 400 mg daily is safe and can progressively reduce Loa loa microfilarial densities in subjects with microfilaremia.
Participants needed: 100
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Programme National de Lutte contre l'Onchocercose, Republic of the CongoUpdated: Sep 26, 2024
Eligibility criteria
Consent informed, written, signed and dated [+3]
Participation in any study other than a purely observational study, within the 4... [+16]